CAS NO: | 579-56-6 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
200mg | 电议 |
500mg | 电议 |
1 g | 电议 |
生物活性 | Isoxsuprine hydrochloride is abeta-adrenergic receptoragonist withKis of 13.65 μΜ and 3.48 μΜ for myometrial and placcntal beta-adrenergic receptor, respectively. Isoxsuprine hydrochloride is also aNMDA receptorantagonist. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体外研究 (In Vitro) | Results show that Isoxsuprine hydrochloride inhibits circular chemorepellent induced defect (CCID) formation dose dependently (5 to 60 μM) and also inhibits 12(S)-HETE synthesis. Furthermore, Isoxsuprine hydrochloride is the only drug inhibiting the induction of all three mobility markers (MLC2, MYPT and paxillin)[2]. | ||||||||||||||||
体内研究 (In Vivo) | Total infarct volume in vehicle-treated animals is 279±25 mm3compare to 137±18 mm3in Isoxsuprine hydrochloride-treated animals[3]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 337.84 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C18H24ClNO3 | ||||||||||||||||
CAS 号 | 579-56-6 | ||||||||||||||||
中文名称 | 去氧肾上腺素杂质31 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 140 mg/mL(414.40 mM;Need ultrasonic) H2O : 15.56 mg/mL(46.06 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|